These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children. Lung DC; Yip EK; Lam DS; Que TL Pediatr Infect Dis J; 2013 Dec; 32(12):1396-9. PubMed ID: 23817339 [TBL] [Abstract][Full Text] [Related]
6. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy. Lung DC; Chan YH; Kwong L; Que TL Hong Kong Med J; 2011 Oct; 17(5):407-9. PubMed ID: 21979480 [TBL] [Abstract][Full Text] [Related]
7. Survey of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in Switzerland. Meyer Sauteur PM; Bleisch B; Voit A; Maurer FP; Relly C; Berger C; Nadal D; Bloemberg GV Swiss Med Wkly; 2014; 144():w14041. PubMed ID: 25254315 [No Abstract] [Full Text] [Related]
10. Resurgence of Mycoplasma pneumonia by macrolide-resistant epidemic clones in China. Li H; Li S; Yang H; Chen Z; Zhou Z Lancet Microbe; 2024 Jun; 5(6):e515. PubMed ID: 38244553 [No Abstract] [Full Text] [Related]
11. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients. Kawai Y; Miyashita N; Yamaguchi T; Saitoh A; Kondoh E; Fujimoto H; Teranishi H; Inoue M; Wakabayashi T; Akaike H; Ogita S; Kawasaki K; Terada K; Kishi F; Ouchi K Respirology; 2012 Feb; 17(2):354-62. PubMed ID: 22077195 [TBL] [Abstract][Full Text] [Related]
13. Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia. Yoon IA; Hong KB; Lee HJ; Yun KW; Park JY; Choi YH; Kim WS; Lee H; Eun BW; Ahn YM; Cho EY; Cho HJ; Choi EH BMC Infect Dis; 2017 Jun; 17(1):402. PubMed ID: 28592263 [TBL] [Abstract][Full Text] [Related]
14. Macrolide-resistant Mycoplasma pneumoniae in children in Taiwan. Wu HM; Wong KS; Huang YC; Lai SH; Tsao KC; Lin YJ; Lin TY J Infect Chemother; 2013 Aug; 19(4):782-6. PubMed ID: 23196653 [TBL] [Abstract][Full Text] [Related]
15. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia. Zhou Y; Wang J; Chen W; Shen N; Tao Y; Zhao R; Luo L; Li B; Cao Q BMC Infect Dis; 2020 Aug; 20(1):633. PubMed ID: 32847534 [TBL] [Abstract][Full Text] [Related]
16. Multilocus variable-number tandem-repeat analysis-confirmed emergence of a macrolide resistance-associated mutation in Mycoplasma pneumoniae during macrolide therapy for interstitial pneumonia in an immunocompromised child. Hantz S; Garnier F; Peuchant O; Menetrey C; Charron A; Ploy MC; Bébéar C; Pereyre S J Clin Microbiol; 2012 Oct; 50(10):3402-5. PubMed ID: 22814468 [TBL] [Abstract][Full Text] [Related]
18. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. Morozumi M; Takahashi T; Ubukata K J Infect Chemother; 2010 Apr; 16(2):78-86. PubMed ID: 20094751 [TBL] [Abstract][Full Text] [Related]
19. Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015. Brown RJ; Macfarlane-Smith L; Phillips S; Chalker VJ Euro Surveill; 2015; 20(48):30078. PubMed ID: 26675545 [TBL] [Abstract][Full Text] [Related]
20. Phase-shifting of the transmissibility of macrolide-sensitive and resistant Mycoplasma pneumoniae epidemics in Hong Kong, from 2015 to 2018. Zhao S; Musa SS; Qin J; He D Int J Infect Dis; 2019 Apr; 81():251-253. PubMed ID: 30822543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]